Several hundred providers of Evusheld, a COVID-19 antibody treatment for immunocompromised, were removed from a federal dataset March 16, making it even more difficult to locate the therapy, Kaiser Health News reported March 17.
Read the full post on Becker's Hospital Review - Healthcare News
